Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-23T16:22:03.227Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiotic sensitivity and mutation rates to antibiotic resistance in Mycoplasma mycoides ssp. mycoides

Published online by Cambridge University Press:  19 October 2009

D. H. Lee ,
R. J. Miles  and
J. R. M. Inal
D. H. Lee
Affiliation:
Department of Microbiology, Kings College, University of London, Campden Hill Road, London WS 7AH
R. J. Miles
Affiliation:
Department of Microbiology, Kings College, University of London, Campden Hill Road, London WS 7AH
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The antibiotic resistance of Mycoplasma mycoides ssp. mycoides strain T1 was investigated. This strain was resistant to high levels ( > 100 μg ml−1) of rifampicin and nalidixic acid. It was sensitive to streptomycin, spectinomycin and novobiocin; however, single step mutants with high levels of resistance ( > 100 μg ml−1) were readily isolated. With erythromycin and tylosin for which the minimum inhibitory concentration (MIC) for the parent strain was < 0·1 μg ml−1, mutants resistant to > 100 μg ml−1 were obtained in two and three steps respectively. The MIC of tetracycline in single step resistant mutants (0·6 μg ml−1) was tenfold higher than the parent strain, but could not be increased further. There was only a twofold increase in resistance to chloramphenicol in single step mutants. The frequency of resistant mutants varied with the antibiotic and was between 4× 10minuss;6 and 2× 10−8. The mutation rate to antibiotic resistance to streptomycin, spectinomycin, novobiocin, erythromycin and tylosin was between 3× 10−8 and 5× 10−9 per cell per generation. There was a fivefold decrease in mutation rate to resistance to 60 μg ml−1 streptomycin compared to that to 20 μg ml−1.

Type
Research Article
Information
Epidemiology & Infection , Volume 98 , Issue 3 , June 1987 , pp. 361 - 368
Copyright
Copyright © Cambridge University Press 1987

References

REFERENCES

Alexander, H. E., Leidy, G., Redman, W. & Simakow, E. (1950). Experimental basis for prediction of therapeutic efficacy of streptomycin in infections caused by Gram negative bacilli. Pediatrics 5, 78–89.CrossRefGoogle ScholarPubMed
Bryan, L. E. (1982). Bacterial Resistance and Susceptibility to Chemotherapeutic Agents. Cambridge: Cambridge University Press.Google Scholar
Bryan, L. E.Kowand, S. M. & Van Den Elzen, H. M.(1979). Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 15, 7–13.CrossRefGoogle ScholarPubMed
Das, J. & Maniloff, J. (1979). Replication of mycoplasma virus MVL51.IV. Inhibition of viral synthesis by rifampin. Journal of Virology 18, 969–976.CrossRefGoogle Scholar
Domeruth, C. H. (1960). Antibiotic resistance and mutation rates of mycoplasma. Avian Diseases 4, 456–466.CrossRefGoogle Scholar
Ericsson, H. M. & Sherris, J. C.(1971). Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica Section B, Supplement No. 217, 79 A, 1–90.Google Scholar
Hudson, J. R. (1971). Contagious Bovine Pleuropneumonia. FAO Agricultural Studies, No. 86. Rome: FAO.Google Scholar
Hudson, J. R. & Etheridge, J. R. (1965). Contagious bovine pleuropneumonia: Experiments with the antibiotic tylosin. Australian Veterinary Journal 41, 130–135.CrossRefGoogle Scholar
Kenny, G. E. (1978). Mutation frequencies of mycoplasmata toward resistance to antibiotics. In Vitro 14, 338.Google Scholar
Koostra, W. L., Adams, J. N. & Smith, P. F. (1966). In vitro selection and identification of antibiotic-resistant mycoplasma mutants. Journal of Bacteriology 91, 2386–2387.CrossRefGoogle ScholarPubMed
Koutsky, L. A., Stamm, W. E., Brunham, R. C, Stevens, C. E.. Cole, B., Hale, J., Davick, P. & Holmes, K. K. (1983) Persistence of Mycoplasma hominis after therapy: importance of tetracycline-resistance and of coexisting vaginal flora. Sexually Transmitted Diseases 11, 374–381.Google Scholar
Lea, D. E. & Coulson, C. A. (1949). The distribution of the number of mutants in bacterial populations. Journal of Genetics 49, 264–285.CrossRefGoogle ScholarPubMed
Lee, D. H., Miles, R. J., & Beezer, A. E. (1986). Isolation and microcalorimetric characterisation of glucose-negative and pyruvate-negative mutants of Mycoplasma mycoides subsp. mycoides. FEMS Microbiology Letters 34, 283–286.CrossRefGoogle Scholar
Lee, D. H., Miles, R. J., & Perry, B. F. (1985). The mycoplasmacidal properties of sodium hypochlorite. Journal of Hygiene 95, 243–253.CrossRefGoogle ScholarPubMed
Luria, S. E. & Delbrük, M. (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491–511.Google Scholar
Niitu, Y.(1983). Anti-mycoplasmal substances. Yale Journal of Biology and Medicine 56. 831–834.Google Scholar
Pilaszek, J. & Truszczyñski, M. (1980a). Possibility of acquiring and loosing resistance to antibiotics in bovine mycoplasma strains. I. Acquiring and loosing resistance to tylosin. Bulletin of the Veterinary Institute of Pulawy 24, 25–31.Google Scholar
Pilaszek, J. & Truszczyñski, M.(1980b). A possibility of acquiring and loosing resistence to antibiotics in bovine mycoplasma strains. II. Acquiring and loosing resistance to chloramphenicol, oxytetracycline, neomycin, and streptomycin. Bulletin of the Veterinary Institute of Pulawy 24, 31–41.Google Scholar
Pollack, J. D. (1979). Respiratory pathways and energy yielding mechanisms. In The Mycoplasmas, vol. 1 (ed. Barile, M. F. and Razin, S.), pp. 188–212. New York: Academic Press.Google Scholar
Razin, S. (1985). Molecular biology and genetics of mycoplasmas (mollicutes). Microbiological Reviews 49, 419–455.Google Scholar
Roberts, M. C. & Kenny, G. E.(1986). Dissemination of the tet M tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrobial Agents and Chemotherapy 29, 350–352.CrossRefGoogle Scholar
Roberts, M. C, Koutsky, L. A., Holmes, K. K., Le Blanc, D. J. & Kenny, G. E. (1985). Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrobial Agents and Chemotherapy 28, 141–143.CrossRefGoogle ScholarPubMed
Robertson, J. A., Coppola, J. E. & Heisler, O. R. (1981). Standardised method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin. Antimicrobial Agents and Chemotherapy 20, 53–58.CrossRefGoogle ScholarPubMed
Savva, D. (1980). A study of some factors affecting mutation rates in bacteria. Ph. D. Thesis, University of London.Google Scholar
Snyder, R. J., Kohner, P. C, Ilstrup, D. M. & Washington, J. A. (1976). Analysis of certain variables in the agar dilution susceptibility test. Antimicrobial Agents and Chemotherapy 9, 74–76.CrossRefGoogle ScholarPubMed
Turner, A. W. (1960). Growth inhibition tests with Mycoplasma mycoides as a basis for chemotherapy and selective culture media. Australian Veterinary Journal 36, 221–224.CrossRefGoogle Scholar
Washington, J. A. & Barry, A. L.(1974). Dilution test procedures. In Manual of Clinical Microbiology(ed. Lennette, E. H., Spaulding, E. H. and Truant, J. P.), 2nd ed., pp. 410–417. Washington D.C.: American Society for Microbiology.Google Scholar